Frequent detection of BRAFV600E mutations in histiocytic and dendritic cell neoplasms

Histopathology

Volumn 65, Issue 2, 2014, Pages 261-272

  Go, Heounjeong ^a   Jeon, Yoon Kyung ^b,c   Huh, Jooryung ^a   Choi, Suk Jin ^d   Choi, Yoo Duk ^e   Cha, Hee Jeong ^a   Kim, Hyun Jung ^f   Park, Gyeongsin ^g   Min, Sookee ^h   Kim, Ji Eun ^b,i  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Inha University Hospital   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Hallym University   (South Korea)

ⁱ Seoul National University Boramae Hospital   (South Korea)

Author keywords

Follicular dendritic cell sarcoma; Frequency; Histiocytic and dendritic cell neoplasms; Histiocytic sarcoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ACUTE MONOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DENDRITIC CELL NEOPLASM; FEMALE; FOLLICULAR DENDRITIC CELL SARCOMA; GENE MUTATION; GENE SEQUENCE; GIANT CELL TUMOR; HISTIOCYTE; HISTIOCYTIC NEOPLASM; HISTIOCYTIC SARCOMA; HOSPITAL; HUMAN; INFORMATION CENTER; INTERDIGITATING CELL; INTERDIGITATING DENDRITIC CELL SARCOMA; KOREA; LANGERHANS CELL HISTIOCYTOSIS; LANGERHANS CELL SARCOMA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PATHOGENESIS; PLASMA CELL GRANULOMA; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOMA; SINUS HISTIOCYTOSIS; WILD TYPE; XANTHOGRANULOMA; XANTHOGRANULOMA INFLAMMATORY MYOFIBROBLASTIC TUMOR; GENETICS; INFANT; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDER; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84904320952     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12416     Document Type: Article

References (25)

1. Michaloglou C, Vredeveld LC, Mooi WJ, Peeper DS. BRAF(e600) in benign and malignant human tumours. Oncogene 2008; 27; 877-895.
2. Tiacci E, Trifonov V, Schiavoni G et al. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 2011; 364; 2305-2315.
3. Lohr JG, Stojanov P, Lawrence MS et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl Acad. Sci. USA 2012; 109; 3879-3884.
4. Arcaini L, Zibellini S, Boveri E et al. The BRAF v600e mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 2012; 119; 188-191.
5. Badalian-Very G, Vergilio JA, Degar BA et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010; 116; 1919-1923.
6. Haroche J, Charlotte F, Arnaud L et al. High prevalence of BRAF v600e mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012a; 120; 2700-2703.
7. Sahm F, Capper D, Preusser M et al. BRAFv600e mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 2012; 120; e28-e34.
8. Swerdlow S, Campo E, Harris N et al. eds. Who classification of tumors of haematopoietic and lymphoid tissue. Geneva: IARC, 2008.
9. LeBoit P, Burg G, Weedon D, Sarasin A. World health organization classification of tumours: pathology and genetics of tumours of the skin. Lyon, France: IARC, 2006.
10. Wilejto M, Abla O. Langerhans cell histiocytosis and Erdheim-Chester disease. Curr. Opin. Rheumatol. 2012; 24; 90-96.
11. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br. J. Haematol. 2012; 156; 163-172.
12. Jaffe E, Harris N, Vardiman J, Campo E, Arber D eds. Hematopathology. Elsevier Saunders: St Louis, MO, 2011.
13. Kim SJ, Lee KE, Myong JP et al. BRAF v600e mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J. Surg. 2012; 36; 310-317.
14. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009; 27; 669-692.
15. Wulling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum. Pathol. 2003; 34; 983-993.
16. Yousem SA, Dacic S, Nikiforov YE, Nikiforova M. Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF v600e mutations. Chest 2013; 143; 1679-1684.
17. Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J. Clin. Pathol. 2013; 66; 79-89.
18. Jeong D, Jeong Y, Park JH et al. BRAF (v600e) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Ann. Surg. Oncol. 2013; 20; 759-766.
19. Pileri SA, Grogan TM, Harris NL et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41; 1-29.
20. Bucsky P, Favara B, Feller AC et al. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: guidelines for differential diagnosis - report of the Histiocyte Society. Med. Pediatr. Oncol. 1994; 22; 200-203.
21. Chang CS, Wang CH, Su IJ, Chen YC, Shen MC. Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. J. Formos. Med. Assoc. 1994; 93; 421-428.
22. Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations. Reclassification working group of the Histiocyte Society. Med. Pediatr. Oncol. 1997; 29; 157-166.
23. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am. J. Surg. Pathol. 2004; 28; 1133-1144.
24. Haroche J, Cohen-Aubart F, Emile JF et al. Dramatic efficacy of Vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF v600e mutation. Blood 2012b; 121; 1495-1500.
25. Choe JY, Go H, Jeon YK et al. Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: a report of six cases with increased IgG4-positive plasma cells. Pathol. Int. 2013; 63; 245-251.